Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial
J. Beissbarth, N. Wilson, B. Arrowsmith, M. J. Binks, V. M. Oguoma, K. Lawrence, A. Llewellyn, E. K. Mulholland, M. Santosham, P. S. Morris, H. C. Smith-Vaughan, A. C. Cheng, A. J. Leach
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial'. Together they form a unique fingerprint.